Alzamend Neuro ALZN
NASDAQ ALZN
$1.37 +0.05 (+3.79%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alzamend Neuro (ALZN) Non Operating Interest Expenses (2020 - 2026)

Updated

Alzamend Neuro (ALZN) recorded Non Operating Interest Expenses of $2,005 in fiscal Q1 2027 (quarter ended Jul 31, 2026), down 19.3% from $2,483 a year earlier.

Analysis

Alzamend Neuro (ALZN) Non Operating Interest Expenses (2020 - 2026) Analysis & Trends

On a TTM basis, Alzamend Neuro's Non Operating Interest Expenses came in at $6,141 as of Jul 31, 2026, down 27.8% year-over-year; for FY2026 (ended Apr 30, 2026), it came in at $6,619, down 63.3% from FY2025.

  • Annual Non Operating Interest Expenses has a five-year compound annual growth rate of -45.9% (FY2021 to FY2026).
  • Across earlier fiscal years, Non Operating Interest Expenses came in at $18,029 in FY2025 (+78.5%), $10,101 in FY2024 (+31.2%), $7,701 in FY2023 (-83.4%) and $46,524 in FY2022 (-67.3%).
  • Quarterly Non Operating Interest Expenses has ranged from $150.00 in fiscal Q4 2026 to $16,299 in fiscal Q3 2022 over the past five years.
  • On a year-over-year basis, Non Operating Interest Expenses has declined for eight consecutive quarters, with an average decline of 41.3% over the last eight quarters.
  • Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 554.3% in fiscal Q1 2025, against a decline of 98.2% in fiscal Q4 2022 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $150.00 (Q4 2026), $1,337 (Q3 2026) and $2,649 (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 281.00 Mn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -435.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 247.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Alzamend Neuro 6.37 Mn 6.37 Mn - 2,005.00
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 2,005.00
Apr 30, 2026 150.00
Jan 31, 2026 1,337.00
Oct 31, 2025 2,649.00
Jul 31, 2025 2,483.00
Apr 30, 2025 509.00
Jan 31, 2025 2,019.00
Oct 31, 2024 3,495.00
Jul 31, 2024 12,006.00
Apr 30, 2024 1,465.00
Jan 31, 2024 2,488.00
Oct 31, 2023 4,311.00
Jul 31, 2023 1,835.00
Apr 30, 2023 519.00
Jan 31, 2023 2,062.00
Oct 31, 2022 3,588.00
Jul 31, 2022 1,532.00
Apr 30, 2022 602.00
Jan 31, 2022 16,299.00
Oct 31, 2021 15,995.00
API Access

Alzamend Neuro Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ALZN&period=max&api_key=YOUR_API_KEY